Berwick’s First Strike: Susan G. Komen Foundation and Ovarian Cancer Alliance Decry First-Ever Medicare Denials of FDA-Approved Cancer Drugs

via HotAir, I thought Don was keeping a low profile but google alerts shows him jumping into denial mode fast, .

Just days after the recess appointment of Donald Berwick, the controversial new head of Medicare and Medicaid, the Ovarian Cancer National Alliance posted the following grim news: for the first time in history, an FDA-approved anti-cancer therapy may not be covered by Medicare.

All focused on outcomes and evidenced based I'm sure in sound Health Geek Analyst way for sure.